Research Groups and R&D Platforms: In Vitro Diagnostics

Research Group:
Molecular determinants of picornaviral disease

Petri Susi
pesusi[at]utu.fi

Institute of Biomedicine,
University of Turku

Petri Susi

Molecular determinants of picornaviral disease

AIROPico

Asthma, Basic research, Bioinformatics, Biomarker, Biotechnology, Cancer, Electron microscopy, Epidemiology, Genomics, Imaging, Imaging software, In Vitro Diagnostics, Infection, Molecular Biology, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Point of care, Target discovery, Virology

Research Group:
High sensitivity multiplex point-of-care assay systems for the detection of blood borne infections in emergency settings (Indo-Finland joint project)

Kim Pettersson
kim.pettersson[at]utu.fi

Department of Biochemistry,
University of Turku

Kim Pettersson

Antibodies, Assay development, Biomarker, Biotechnology, Electron microscopy, In Vitro Diagnostics, Infection, Nanoparticles, Virology

Research Group:
Viruses in the development of chronic lung diseases

Tytti Vuorinen
tytti.vuorinen[at]utu.fi

Institute of Biomedicine,
University of Turku

Tytti Vuorinen

Viruses in the development of chronic lung diseases

Allergy, Assay development, Asthma, Clinical Medicine, Disease models, Genomics, In Vitro Diagnostics, Infection, Inflammation, Molecular diagnostics, Point of care, Virology

Research Group:
Bone and energy metabolism

Kaisa Ivaska
kaisa.ivaska[at]utu.fi

Institute of Biomedicine,
University of Turku

Kaisa Ivaska

Ageing-related diseases, Assay development, Basic research, Biomarker, Biomedicine, Diabetes, In Vitro Diagnostics, Metabolic diseases, Molecular Cell Biology, Musculoskeletal disorders, Obesity

Research Group:
Neuronal Signalling Pathways

Michael Courtney
miccou[at]utu.fi                    

Neuronal Signalling Laboratory
Turku Bioscience
University of Turku

Michael Courtney

Neuronal Signalling Pathways

Ageing-related diseases, Assay development, Basic research, Biochemistry, Biomarker, Biomedicine, Biotechnology, Cancer, Data mining, Disease models, Drug delivery, Drug target, Fluorescence spectroscopy, High throughput imaging, Hit to lead, Imaging, Imaging software, In Vitro Diagnostics, Molecular Biology, Molecular Cell Biology, Molecular modelling, Natural Compounds, Natural products, Neurological disorders, Organic compounds, Pharmacology, Screening, Signaling, Synthetic Biology, Target discovery

Research Group:
Molecular Systems Immunology

Riitta Lahesmaa

Contact person: Anne Lahdenperä, anne.lahdenpera[at]bioscience.fi

Molecular Immunology Group,
Turku Bioscience,

University of Turku

Riitta Lahesmaa

Molecular Systems Immunology

Allergy, Asthma, Autoimmune diseases, Basic research, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Cancer, Cardiovascular diseases, Data mining, Diabetes, Diagnostics, Epigenomics, Genomics, Immunology, In Vitro Diagnostics, Infection, Inflammation, Metabolic diseases, Molecular Biology, Molecular Cell Biology, Next-generation sequencing, Personalized medicine, Proteomics, Receptor, Signaling, Systems Biology, Target discovery